All Stories

  1. Natural T Cell–mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study
  2. Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink
  3. Impact of infection control interventions on rates of Staphylococcus aureus bacteraemia in National Health Service acute hospitals, East Midlands, UK, using interrupted time-series analysis
  4. Healthcare workers' willingness to work during an influenza pandemic: a systematic review and meta-analysis
  5. From the Editor's desk
  6. Neuraminidase inhibitors: who, when, where?
  7. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial ‘in hibernation’, ready for rapid activation
  8. Reply: Letter to the Editor, Cochrane Rearranged
  9. Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies
  10. Cochrane Column
  11. Effect of Corticosteroid Therapy on Influenza-Related Mortality: A Systematic Review and Meta-analysis
  12. Influenza Vaccination Among Australian Hajj Pilgrims: Uptake, Attitudes, and Barriers
  13. Neuraminidase inhibitors for influenza complications–Authors' reply
  14. Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review
  15. Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK
  16. Antivirals for influenza: where now for clinical practice and pandemic preparedness?
  17. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
  18. Principal author of PRIDE study responds to news story in The BMJ claiming that the study was based on "flawed" analysis
  19. Disease Surveillance and Global Health Security
  20. Guidance on the use of respiratory and facial protection equipment
  21. The first recorded outbreak of cryptosporidiosis due to Cryptosporidium cuniculus (formerly rabbit genotype), following a water quality incident
  22. An Evaluation of Community Assessment Tools (CATs) in Predicting Use of Clinical Interventions and Severe Outcomes during the A(H1N1)pdm09 Pandemic
  23. Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review
  24. Routes of influenza transmission
  25. Pandemic preparedness and response
  26. Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines
  27. Intervention strategies for emerging respiratory virus infections: policy and public health considerations
  28. Corticosteroids as adjunctive therapy in the treatment of influenza
  29. Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic – The Risk of Aerosol Generation during Medical Procedures
  30. Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03A-Adjuvanted H1N1 2009 Vaccine
  31. Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)
  32. Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic
  33. Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients
  34. Influenza aerosols in UK hospitals during the influenza H1N1 (2009–10) pandemic: air sampling in the vicinity of patients undergoing WHO-defined aerosol generating procedures
  35. Pre-existing immunity in human challenge studies of influenza transmission – Authors' reply
  36. Influenza and other respiratory viral infections
  37. Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis by Etiology
  38. Differences between asthmatics and nonasthmatics hospitalised with influenza A infection
  39. The Comparative Clinical Course of Pregnant and Non-Pregnant Women Hospitalised with Influenza A(H1N1)pdm09 Infection
  40. Vaccination of Health Care Workers to Protect Patients at Increased Risk for Acute Respiratory Disease
  41. Did pandemic preparedness aid the response to pandemic (H1N1) 2009? A qualitative analysis in seven countries within the WHO European Region
  42. Comparison of CATs, CURB-65 and PMEWS as Triage Tools in Pandemic Influenza Admissions to UK Hospitals: Case Control Analysis Using Retrospective Data
  43. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
  44. A New Sentinel Surveillance System for Severe Influenza in England Shows a Shift in Age Distribution of Hospitalised Cases in the Post-Pandemic Period
  45. Unmasking Masks in Makkah: Preventing Influenza at Hajj
  46. Use of a Human Influenza Challenge Model to Assess Person-to-Person Transmission: Proof-of-Concept Study
  47. Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control
  48. Doctors accepting flu vaccination is the sensible and responsible choice
  49. Potential role of human challenge studies for investigation of influenza transmission
  50. Authors' response
  51. Use of Antiviral Drugs to Reduce Household Transmission of Pandemic (H1N1) 2009, United Kingdom1
  52. Use of Antiviral Drugs to Reduce Household Transmission of Pandemic (H1N1) 2009, United Kingdom1
  53. Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease
  54. Nosocomial Pandemic (H1N1) 2009, United Kingdom, 2009–2010
  55. Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic
  56. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
  57. Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
  58. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy
  59. A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart
  60. Evaluation of inter-pandemic influenza vaccine effectiveness during eight consecutive winter seasons in England and Wales in patients with cardiovascular risk factors
  61. Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
  62. Epidemic and pandemic influenza
  63. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)
  64. Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience
  65. Effectiveness of Common Household Cleaning Agents in Reducing the Viability of Human Influenza A/H1N1
  66. An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998–1999 to 2005–2006
  67. Personal protective equipment in an influenza pandemic: a UK simulation exercise
  68. Introduction to pandemic influenza
  69. Minimum dataset for confirmed human cases of influenza H5N1
  70. Bacterial Pneumonia and Pandemic Influenza Planning
  71. What happens to medical students who complete an honours year in public health and epidemiology?
  72. Responding to bird influenza: Past, present and future
  73. Pandemic Infection Control for Critical Care
  74. Avian influenza and the threat of the next human pandemic
  75. Public health responses to influenza in care homes: a questionnaire-based study of local Health Protection Units
  76. Influenza vaccination coverage rates in the UK: A comparison of two monitoring methods during the 2002–2003 and 2003–2004 seasons
  77. Public Understanding of Pandemic Influenza, United Kingdom
  78. Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom
  79. Costs of running a universal adolescent hepatitis B vaccination programme
  80. Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain
  81. The epidemiology and clinical impact of pandemic influenza
  82. Adverse medical events in British service personnel following anthrax vaccination
  83. Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care
  84. Capecitabine monotherapy in metastatic colorectal cancer
  85. Phylogenetic Analysis of Multiple Heterosexual Transmission Events Involving Subtype B of HIV Type 1
  86. What happens to medical students who complete an honours year in public health and epidemiology?
  87. Excess hospital admissions for pneumonia and influenza in persons [ges ]65 years associated with influenza epidemics in three English health districts: 1987–95
  88. Influenza outbreaks in elderly care institutions
  89. 022 A heterosexual outbreak in Doncaster involving subtype B of HIV-1: molecular epidemiology as a supplement to contact tracing
  90. Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control
  91. Influenza outbreaks in elderly care institutions
  92. Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report
  93. Do Influenza Epidemics Affect Patterns of Sickness Absence Among British Hospital Staff?
  94. Zanamivir for influenza: a public health perspective
  95. Family doctor advice is the main determinant of pneumococcal vaccine uptake
  96. Invasive meningocccal disease among university undergraduates association with catered halls of residence
  97. Rapid large increase in meningococcal carriage rates in first year university students
  98. Carriage of neisseria meningitidis in a village community after mass antibiotic and vaccine programmes
  99. Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation
  100. Risk factors for hospital-acquired urinary tract infection in a large English teaching hospital: A case-control study
  101. "Late presenters" after paracetamol self poisoning
  102. Age is not only criterion for flu vaccine
  103. Who dies from hernia?
  104. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma
  105. Effectiveness of ambulance paramedics versus ambulance technicians in managing out of hospital cardiac arrest.
  106. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemic
  107. Hidden impact of paramedic interventions.
  108. Vietnamese people in study may have had language difficulties
  109. Influenza vaccine effectiveness during the 1989–90 epidemic
  110. Is there a synergistic effect between previous and current vaccination against influenza?
  111. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
  112. Do Cadet Force Units need a Dedicated Medical Pack?
  113. Deficiencies in undergraduate and pre-registration medical training in prescribing for pain controlShort Communication
  114. Uptake of influenza vaccine
  115. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery
  116. Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season
  117. Protective efficacy of BCG vaccine against leprosy in southern Malaŵi
  118. Non-steroidal anti-inflammatory drugs and appendicitis in patients aged over 50 years
  119. General practice and accident and emergency department care: does the patient know best?
  120. Influenza deaths in Leicestershire during the 1989–90 epidemic: implications for prevention
  121. BCG vaccine and leprosy
  122. Adolescents' desires and beliefs about motorcycling: implications for education
  123. Pharmaceutical interventions.